A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status

Fertility and Sterility

Volumn 93, Issue 1, 2010, Pages 192-198

  Parsanezhad, Mohammad Ebrahim ^a   Azmoon, Mina ^a   Alborzi, Saeed ^a   Rajaeefard, Abdoreza ^a   Zarei, Afsun ^a   Kazerooni, Talieh ^a   Frank, Vivian ^b   Schmidt, Ernst Hienrich ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

aromatose inhibitor; GnRha; medical therapy; myoma; Uterus

Indexed keywords

DIPHERELINE; ESTRADIOL; FOLLITROPIN; LETROZOLE; LUTEINIZING HORMONE; TRIPTORELIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HORMONE BLOOD LEVEL; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PREMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; TREATMENT DURATION; TUMOR VOLUME; UNIVERSITY HOSPITAL; UTERUS MYOMA;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; AROMATASE INHIBITORS; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; GERMANY; GONADOTROPIN-RELEASING HORMONE; HORMONES; HOSPITALS, UNIVERSITY; HOT FLASHES; HUMANS; IRAN; LEIOMYOMA; LUTEINIZING HORMONE; NITRILES; PROSPECTIVE STUDIES; TESTOSTERONE; TIME FACTORS; TREATMENT OUTCOME; TRIAZOLES; TRIPTORELIN; TUMOR BURDEN; UTERINE NEOPLASMS;

EID: 72749091561     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.09.064     Document Type: Article

References (44)

1. Cheng M.H., and Wang P.H. Uterine myoma: a condition amenable to medical therapy?. Expert Opin Emerg Drugs 13 (2008) 119-133
2. Haney A.F. Clinical decision making regarding leiomyomata: what we need in the next millennium. Environ Health Perspect 108 Suppl 5 (2000) 835-839
3. Brandon D.D., Erickson T.E., Keenan E.J., Strawn E.Y., Novy M.J., Burry K.A., et al. Estrogen receptor gene expression in human uterine leiomyomata. J Clin Endocrinol Metab 80 (1995) 1876-1881
4. Bulun S.E., Simpson E.R., and Word R.A. Expression of the CYP19 gene and its product aromatase cytochrome P450 in human uterine leiomyoma tissues and cells in culture. J Clin Endocrinol Metab 78 (1994) 736-743
5. Sumitani H., Shozu M., Segawa T., Murakami K., Yang H.J., Shimada K., et al. In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine/intracrine mechanism. Endocrinology 141 (2000) 3852-3861
6. Gabb R.G., and Stone G.M. Uptake and metabolism of tritiated oestradiol and oestrone by human endometrial and myometrial tissue in vitro. J Endocrinol 62 (1974) 109-123
7. Pollow K., Sinnecker G., Boquoi E., and Pollow B. In vitro conversion of estradiol-17beta into estrone in normal human myometrium and leiomyoma. J Clin Chem Clin Biochem 16 (1978) 493-502
8. Eiletz J., Genz T., Pollow K., and Schmidt-Gollwitzer M. Sex steroid levels in serum, myometrium, and fibromyomata in correlation with cytoplasmic receptors and 17 beta-HSD activity in different age-groups and phases of the menstrual cycle. Arch Gynecol 229 (1980) 13-28
9. Newton C.J., and James V.H. 17 beta-hydroxysteroid dehydrogenase activity in leiomyoma and myometrium and its relationship to concentrations of oestrone, oestradiol and progesterone throughout the menstrual cycle. J Steroid Biochem 22 (1985) 487-493
10. Bulun S.E., Imir G., Utsunomiya H., Thung S., Gurates B., Tamura M., et al. Aromatase in endometriosis and uterine leiomyomata. J Steroid Biochem Mol Biol 95 (2005) 57-62
11. Wallach E.E., and Vlahos N.F. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol 104 (2004) 393-406
12. Lepine L.A., Hillis S.D., Marchbanks P.A., Koonin L.M., Morrow B., Kieke B.A., et al. Hysterectomy surveillance-United States, 1980-1993. MMWR CDC Surveill Summ 46 (1997) 1-15
13. Stewart E.A. Uterine fibroids. Lancet 357 (2001) 293-298
14. Donnez J., and Jadoul P. What are the implications of myomas on fertility? A need for a debate?. Hum Reprod 17 (2002) 101-107
15. Myers E.R., Goodwin S., Landow W., Mauro M., Peterson E., Pron G., et al. Prospective data collection of a new procedure by a specialty society: the FIBROID registry. Obstet Gynecol 106 (2005) 44-51
16. Smart O.C., Hindley J.T., Regan L., and Gedroyc W.G. Gonadotropin releasing hormone and magnetic-resonance guided ultrasound surgery for uterine leiomyoma. Obstet Gynecol 108 (2006) 49-54
17. Dickner S.K., Cooper J.M., and Diaz D. A nonincisional, Doppler-guided transvaginal approach to uterine artery identification and control of uterine perfusion. J Am Assoc Gynecol Laparosc 11 (2004) 55-58
18. Vilos G.A., Vilos E.C., Romano W., and Abu-Rafea B. Temporary uterine artery occlusion for treatment of menorrhagia and uterine fibroids using an incisionless Doppler-guided transvaginal clamp: case report. Hum Reprod 21 (2006) 269-271
19. De Leo V., la Marca A., and Morgante G. Short-term treatment of uterine fibromyomas with danazol. Gynecol Obstet Invest 47 (1999) 258-262
20. De Leo V., Morgante G., La Marca A., Musacchio M.C., Sorace M., Cavicchioli C., et al. A benefit-risk assessment of medical treatment for uterine leiomyomas. Drug Saf 25 (2002) 759-779
21. Palomba S., Sammartino A., Di Carlo C., Affinito P., Zullo F., and Nappi C. Effects of raloxifene treatment on uterine leiomyomas in postmenopausal women. Fertil Steril 76 (2001) 38-43
22. Palomba S., Orio Jr. F., Morelli M., Russo T., Pellicano M., Zupi E., et al. Raloxifene administration in premenopausal women with uterine leiomyomas: a pilot study. J Clin Endocrinol Metab 87 (2002) 1502-1508
23. Friedman A.J., Rein M.S., Harrison-Atlas D., Garfield J.M., and Doubilet P.M. A randomized, placebo controlled, double-blind study evaluating leuprolide acetate depot treatment before myomectomy. Fertil Steril 52 (1989) 728-733
24. Fedele L., Vercellini P., Bianchi S., Brioschi D., and Dorta M. Treatment with GnRH agonists before myomectomy and the risk of short term myoma recurrence. Br J Obstet Gynaecol 97 (1990) 393-396
25. Shaw R.W. Mechanism of LHRH analogue action in uterine fibroids. Horm Res 32 Suppl 1 (1989) 150-153
26. Golan A., Bukovsky I., Pansky M., Schneider D., Weinraub Z., and Caspi E. Pre-operative gonadotrophin-releasing hormone agonist treatment in surgery for uterine leiomyomata. Hum Reprod 8 (1993) 450-452
27. Zullo F., Pellicano M., De Stefano R., Zupi E., and Mastrantonio P. A prospective randomized study to evaluate leuprolide acetate treatment before laparoscopic myomectomy: efficacy and ultrasonographic predictors. Am J Obstet Gynecol 178 (1998) 108-112
28. Campo S., and Garcea N. Laparoscopic myomectomy in premenopausal women with and without preoperative treatment using gonadotrophin-releasing hormone analogues. Hum Reprod 14 (1999) 44-48
29. Stovall T.G., Muneyyirci-Delale O., Summitt Jr. R.L., and Scialli A.R. GnRH agonist and iron versus placebo and iron in the anemic patient before surgery for leiomyomas: a randomized controlled trial. Leuprolide Acetate Study Group. Obstet Gynecol 86 (1995) 65-71
30. Hornstein M.D., Surrey E.S., Weisberg G.W., and Casino L.A. Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group. Obstet Gynecol 91 (1998) 16-24
31. Shozu M., Murakami K., Segawa T., Kasai T., and Inoue M. Successful treatment of a symptomatic uterine leiomyoma in a perimenopausal woman with a nonsteroidal aromatase inhibitor. Fertil Steril 79 (2003) 628-631
32. Bozzini N., Rodrigues C.J., Petti D.A., Bevilacqua R.G., Goncalves S.P., and Pinotti J.A. Effects of treatment with treatment with gonadotropin releasing hormone agonist on the uterine leiomyomata structure. Acta Obstet Gynecol Scand 82 (2003) 330-334
33. Adamson G.D. Treatment of uterine fibroids: current findings with gonadotropin releasing hormone agonist. Am J Obstet Gynecol 166 (1992) 746-751
34. Perry C.M., Brogden R.N., and Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in benign gynaecological disorders. Drugs 51 (1996) 319-346
35. Sumitani H., Shozu M., Segawa T., Murakami K., Yang H.-J., Shimada K., et al. In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine/intracrine mechanism. Endocrinology 141 (2000) 3852-3861
36. Pasqualini J.R., Cornier E., Grenier J., Vella C., Schatz B., and Netter A. Effect of decapeptyl, an agonistic analog of gonadotropin-releasing hormone on estrogens, estrogen sulfates, and progesterone receptors in leiomyoma and myometrium. Fertil Steril 53 (1990) 1012-1017
37. Shozu M., Murakami K., and Inoue M. Aromatase and leiomyoma of the uterus. Semin Reprod Med 22 (2004) 51-60
38. Shozu M., Murakami K., Segawa T., Kasai T., and Inoue M. Successful treatment of a symptomatic uterine leiomyoma in a perimenopausal woman with a nonsteroidal aromatase inhibitor. Fertile Steril 79 (2003) 628-631
39. Iveson T.J., Smith I.E., Ahern J., Smithers D.A., Trunet P.F., and Dowsett M. Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in postmenopausal patients with advanced breast cancer. Cancer Res 53 (1993) 266-270
40. Harding S.G., Pesce A., and McMillan L. Symptomatic ascites complicating GnRH analogue use for myoma shrinkage. Br J Obstet Gynaecol 100 (1993) 1054-1056
41. Friedman A.J. Acute urinary retention after gonadotropin-releasing hormone agonist treatment for leiomyomata uteri. Fertil Steril 59 (1993) 677-678
42. Hansen L.M., Batzer F.R., Corson S.L., and Bello S. Obesity and GnRH action. Report of a case with contribution by peripherally derived estrogens. J Reprod Med 42 (1997) 247-250
43. Shozu M., Sumitani H., Segawa T., Yang H.J., Murakami K., Kasai T., et al. Over-expression of aromatase P-450 in leiomyoma tissues is driven through the promoter I.4 of aromatase P-450. J Clin Endocrinol Metab 87 (2002) 2540-2548
44. Mitwally M.F., and Casper R.F. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 75 (2001) 305-309